Radiographic Contrast Agent [EPC]

Radiographic Contrast Agent [EPC] was reported 25804 times

Drugs of the Radiographic Contrast Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CONTRAST ENCEPHALOPATHY 240 0.8696
1 CORONARY NO-REFLOW PHENOMENON 10 0.4000
2 CONTRAST MEDIA ALLERGY 698 0.3808
3 URINE IODINE INCREASED 9 0.3750
4 CONTRAST MEDIA REACTION 711 0.3010
5 SCHIZENCEPHALY 13 0.2889
6 AIR EMBOLISM 114 0.2420
7 HEPATIC ARTERY STENOSIS 30 0.2308
8 POST EMBOLISATION SYNDROME 25 0.2174
9 CEREBRAL HAEMORRHAGE FOETAL 13 0.2131
10 OXYGEN SATURATION IMMEASURABLE 23 0.2091
11 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 24 0.1690
12 SKIN TEMPERATURE INCREASED 13 0.1529
13 CAROTID PULSE ABNORMAL 8 0.1481
14 BILOMA 20 0.1418
15 ALVEOLAR LUNG DISEASE 25 0.1316
16 HEPATIC ARTERY OCCLUSION 11 0.1294
17 ANAPHYLACTOID SHOCK 54 0.1149
18 MENINGITIS CHEMICAL 25 0.1136
19 INADVERTENT INJECTION AIR BUBBLE 14 0.1111
20 BLOOD PRESSURE IMMEASURABLE 150 0.0978
21 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 10 0.0962
22 MENINGITIS FUNGAL 21 0.0894
23 BURKHOLDERIA TEST POSITIVE 9 0.0726
24 LARYNGEAL DISCOMFORT 43 0.0675
25 EXTRAVASATION 249 0.0605
26 AMAUROSIS 50 0.0594
27 RASH SCARLATINIFORM 13 0.0588
28 NONINFECTIVE SIALOADENITIS 9 0.0566
29 SNEEZING 1095 0.0488
30 AGONAL RESPIRATION 13 0.0459
31 NEPHROPATHY TOXIC 459 0.0409
32 TONGUE PRURITUS 35 0.0407
33 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 301 0.0387
34 LARYNX IRRITATION 9 0.0385
35 ANAPHYLACTIC SHOCK 970 0.0376
36 HYPERAEMIA 72 0.0365
37 FOAMING AT MOUTH 71 0.0351
38 CONTRAST MEDIA DEPOSITION 11 0.0349
39 LARYNGEAL OEDEMA 215 0.0349
40 CIRCUMORAL OEDEMA 12 0.0344
41 IODINE ALLERGY 11 0.0330
42 BLINDNESS CORTICAL 16 0.0327
43 HEPATIC INFARCTION 12 0.0318
44 SPINAL CORD INFARCTION 14 0.0317
45 SEPTIC ARTHRITIS STAPHYLOCOCCAL 11 0.0316
46 SIALOADENITIS 42 0.0308
47 ORAL PRURITUS 70 0.0305
48 CONJUNCTIVAL OEDEMA 31 0.0302
49 ANAPHYLACTOID REACTION 124 0.0301
50 NASAL OBSTRUCTION 55 0.0293
51 RESPIRATORY TRACT OEDEMA 21 0.0283
52 RASH MACULO-PAPULAR 628 0.0282
53 LIP PRURITUS 24 0.0280
54 ANAL SPHINCTER ATONY 12 0.0279
55 ORBITAL OEDEMA 14 0.0277
56 NASAL PRURITUS 34 0.0271
57 CEREBRAL ARTERY EMBOLISM 33 0.0271
58 ABDOMINAL INJURY 14 0.0268
59 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 22 0.0268
60 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 22 0.0268
61 PULSE ABSENT 123 0.0258
62 PATIENT UNCOOPERATIVE 12 0.0253
63 SUBCUTANEOUS EMPHYSEMA 24 0.0244
64 KOUNIS SYNDROME 55 0.0242
65 LIVER ABSCESS 78 0.0240
66 DIFFUSE ALVEOLAR DAMAGE 27 0.0235
67 PULSE ABNORMAL 56 0.0232
68 ANEURYSM RUPTURED 21 0.0229
69 SKIN FIBROSIS 11 0.0227
70 DYSPHORIA 115 0.0227
71 EYELID OEDEMA 263 0.0226
72 ENANTHEMA 13 0.0226
73 SKIN TEST POSITIVE 21 0.0225
74 NEPHROGENIC SYSTEMIC FIBROSIS 68 0.0225
75 TOXIC SKIN ERUPTION 213 0.0211
76 CYANOSIS 317 0.0201
77 RESUSCITATION 33 0.0199
78 PO2 INCREASED 10 0.0197
79 PHARYNGEAL HYPOAESTHESIA 18 0.0194
80 HENOCH-SCHONLEIN PURPURA 42 0.0192
81 EOSINOPHILIA 336 0.0192
82 RESPIRATORY RATE INCREASED 170 0.0191
83 INFUSION SITE EXTRAVASATION 118 0.0189
84 PAPULE 131 0.0186
85 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 477 0.0185
86 THROAT TIGHTNESS 498 0.0184
87 CONJUNCTIVAL HYPERAEMIA 65 0.0182
88 EMBOLIC CEREBRAL INFARCTION 12 0.0181
89 CARDIAC PROCEDURE COMPLICATION 11 0.0181
90 SUSPECTED PRODUCT CONTAMINATION 18 0.0178
91 SLOW RESPONSE TO STIMULI 23 0.0177
92 ARACHNOIDITIS 12 0.0173
93 LIP OEDEMA 72 0.0170
94 FIXED ERUPTION 29 0.0168
95 TONGUE OEDEMA 64 0.0168
96 RASH MORBILLIFORM 46 0.0166
97 TYPE IV HYPERSENSITIVITY REACTION 45 0.0164
98 TACHYPNOEA 223 0.0164
99 ANAPHYLACTIC REACTION 898 0.0162
100 TYPE I HYPERSENSITIVITY 57 0.0162
101 SKIN INDURATION 33 0.0159
102 FACE OEDEMA 264 0.0156
103 GENERALISED ERYTHEMA 89 0.0156
104 URTICARIA 2591 0.0155
105 TONGUE PARALYSIS 11 0.0154
106 SPINAL EPIDURAL HAEMATOMA 9 0.0153
107 STRIDOR 45 0.0153
108 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 50 0.0151
109 SUSPECTED PRODUCT QUALITY ISSUE 27 0.0147
110 INDIFFERENCE 11 0.0146
111 THROAT IRRITATION 650 0.0145
112 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 15 0.0141
113 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 37 0.0141
114 DISORGANISED SPEECH 26 0.0141
115 AMAUROSIS FUGAX 15 0.0139
116 SENSATION OF FOREIGN BODY 117 0.0139
117 PUPILLARY REFLEX IMPAIRED 25 0.0135
118 EYE OEDEMA 33 0.0134
119 SKIN TIGHTNESS 63 0.0134
120 SPLENIC INFARCTION 23 0.0132
121 SKIN OEDEMA 13 0.0130
122 LIVEDO RETICULARIS 27 0.0129
123 SUFFOCATION FEELING 32 0.0129
124 OVERLAP SYNDROME 9 0.0129
125 REDUCED FACIAL EXPRESSION 13 0.0128
126 PHARYNGEAL OEDEMA 197 0.0128
127 BRONCHOSPASM 182 0.0127
128 PHARYNGEAL PARAESTHESIA 20 0.0126
129 PARAPLEGIA 36 0.0125
130 INJECTION SITE OEDEMA 21 0.0122
131 OROPHARYNGEAL DISCOMFORT 110 0.0122
132 UNRESPONSIVE TO STIMULI 314 0.0122
133 ADMINISTRATION SITE EXTRAVASATION 12 0.0120
134 GAZE PALSY 20 0.0117
135 EMBOLISM ARTERIAL 14 0.0116
136 DERMATITIS EXFOLIATIVE GENERALISED 40 0.0115
137 BLOOD PRESSURE DECREASED 764 0.0115
138 ACUTE PULMONARY OEDEMA 64 0.0114
139 UPPER AIRWAY OBSTRUCTION 10 0.0113
140 EAR PRURITUS 39 0.0111
141 CHYLOTHORAX 8 0.0111
142 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 9 0.0110
143 PRODUCT DEPOSIT 17 0.0109
144 SHOCK 251 0.0109
145 ADENOCARCINOMA GASTRIC 10 0.0108
146 PROCEDURAL HYPOTENSION 9 0.0106
147 VENTRICULAR FIBRILLATION 117 0.0105
148 MENINGITIS BACTERIAL 15 0.0105
149 OEDEMA MUCOSAL 11 0.0105
150 LARYNGOSPASM 28 0.0104
151 COMPARTMENT SYNDROME 27 0.0103
152 PARAESTHESIA ORAL 149 0.0103
153 RASH PUSTULAR 75 0.0103
154 HYPORESPONSIVE TO STIMULI 12 0.0102
155 OXYGEN SATURATION DECREASED 572 0.0102
156 OEDEMA MOUTH 33 0.0101
157 PULSELESS ELECTRICAL ACTIVITY 42 0.0100
158 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 22 0.0100
159 NASAL OEDEMA 18 0.0100
160 RENAL TUBULAR NECROSIS 97 0.0099
161 CARDIOVASCULAR INSUFFICIENCY 16 0.0098
162 LOCALISED OEDEMA 45 0.0097
163 PO2 DECREASED 11 0.0096
164 PHARYNGEAL SWELLING 93 0.0095
165 ACUTE LUNG INJURY 11 0.0093
166 DERMATITIS BULLOUS 67 0.0092
167 PERIORBITAL OEDEMA 48 0.0092
168 BILE DUCT STENOSIS 11 0.0092
169 PALLOR 249 0.0091
170 HYPOAESTHESIA ORAL 136 0.0090
171 SWELLING OF EYELID 56 0.0089
172 COLD SWEAT 156 0.0088
173 THYROTOXIC CRISIS 10 0.0088
174 CARBON DIOXIDE DECREASED 10 0.0087
175 HYPERPYREXIA 36 0.0085
176 ASPIRATION 92 0.0084
177 CARDIO-RESPIRATORY ARREST 350 0.0084
178 ASPHYXIA 68 0.0083
179 EAR SWELLING 17 0.0080
180 INJECTION SITE EXTRAVASATION 99 0.0080
181 DERMATITIS EXFOLIATIVE 40 0.0080
182 INCORRECT DRUG ADMINISTRATION RATE 34 0.0080
183 OXYGEN THERAPY 13 0.0079
184 ERYTHEMA 1611 0.0078
185 SKIN HYPERTROPHY 22 0.0078
186 DRUG CLEARANCE DECREASED 10 0.0077
187 EOSINOPHILIC PNEUMONIA 24 0.0076
188 EXTRADURAL HAEMATOMA 10 0.0076
189 ANGIOEDEMA 333 0.0075
190 ARTERIOSPASM CORONARY 30 0.0075
191 RESPIRATORY DISTRESS 203 0.0073
192 CHEST DISCOMFORT 750 0.0073
193 ISCHAEMIC HEPATITIS 10 0.0073
194 INJECTION RELATED REACTION 12 0.0073
195 DYSAESTHESIA 22 0.0072
196 YAWNING 19 0.0071
197 PURPURA 63 0.0071
198 PROCEDURAL COMPLICATION 54 0.0070
199 IATROGENIC INJURY 9 0.0070
200 ERYTHEMA MULTIFORME 65 0.0070
201 URINARY INCONTINENCE 206 0.0069
202 SKIN INJURY 23 0.0069
203 MOUTH SWELLING 40 0.0069
204 DERMATITIS ALLERGIC 87 0.0069
205 EYE PRURITUS 232 0.0069
206 ANAL INCONTINENCE 62 0.0069
207 LIP SWELLING 228 0.0068
208 RASH ERYTHEMATOUS 327 0.0068
209 NEPHROPATHY 63 0.0067
210 PRURITUS 2591 0.0067
211 EYE SWELLING 250 0.0067
212 VEIN RUPTURE 11 0.0066
213 PORTAL VEIN THROMBOSIS 21 0.0065
214 RESPIRATORY ARREST 174 0.0063
215 FEAR OF DEATH 14 0.0062
216 APGAR SCORE LOW 8 0.0062
217 CHILLS 725 0.0062
218 INDURATION 11 0.0062
219 BILIARY OBSTRUCTION 8 0.0062
220 PETECHIAE 64 0.0061
221 RENAL FAILURE ACUTE 257 0.0061
222 NEPHROGENIC ANAEMIA 28 0.0060
223 ANURIA 52 0.0060
224 DRUG ERUPTION 105 0.0059
225 PUSTULE 14 0.0059
226 VOMITING PROJECTILE 17 0.0059
227 CIRCULATORY COLLAPSE 100 0.0059
228 THROAT CLEARING 22 0.0059
229 CARDIAC ARREST 484 0.0059
230 SWOLLEN TONGUE 182 0.0058
231 HYPERAMMONAEMIA 29 0.0058
232 BILIARY TRACT DISORDER 8 0.0058
233 APNOEA 45 0.0058
234 HYPOPNOEA 20 0.0058
235 DYSPHONIA 336 0.0057
236 RESPIRATORY RATE DECREASED 18 0.0057
237 ERYTHEMA OF EYELID 31 0.0057
238 TEMPERATURE INTOLERANCE 59 0.0057
239 BLOOD PRESSURE SYSTOLIC DECREASED 26 0.0057
240 SKIN WARM 33 0.0057
241 CHOLECYSTITIS ACUTE 32 0.0056
242 ACUTE KIDNEY INJURY 864 0.0056
243 PANCREATIC CARCINOMA METASTATIC 16 0.0056
244 SWELLING FACE 366 0.0056
245 SKIN NECROSIS 29 0.0056
246 EYE MOVEMENT DISORDER 38 0.0055
247 PRURITUS GENERALISED 120 0.0055
248 HYPERTHERMIA 42 0.0055
249 BREATH SOUNDS ABNORMAL 27 0.0055
250 ESSENTIAL HYPERTENSION 10 0.0055
251 HYPERTHYROIDISM 79 0.0055
252 CHOKING SENSATION 30 0.0054
253 QUADRIPARESIS 9 0.0054
254 PNEUMOPERITONEUM 10 0.0054
255 LOSS OF CONSCIOUSNESS 691 0.0054
256 MENINGITIS ASEPTIC 24 0.0053
257 RALES 31 0.0053
258 ORTHOPNOEA 17 0.0053
259 BLINDNESS TRANSIENT 39 0.0053
260 ALTERED STATE OF CONSCIOUSNESS 113 0.0052
261 METHAEMOGLOBINAEMIA 12 0.0052
262 GENERALISED OEDEMA 64 0.0052
263 VASCULAR PSEUDOANEURYSM 9 0.0052
264 TOXIC EPIDERMAL NECROLYSIS 78 0.0051
265 HAEMODIALYSIS 43 0.0051
266 BRAIN OEDEMA 64 0.0051
267 MACULE 14 0.0050
268 ACUTE RESPIRATORY FAILURE 96 0.0050
269 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 19 0.0050
270 EOSINOPHIL COUNT INCREASED 41 0.0049
271 NASAL CONGESTION 286 0.0049
272 FLUSHING 492 0.0048
273 CARDIOGENIC SHOCK 69 0.0048
274 INTERVERTEBRAL DISCITIS 9 0.0048
275 LACRIMATION INCREASED 143 0.0047
276 TONGUE DISORDER 34 0.0047
277 DEPRESSED LEVEL OF CONSCIOUSNESS 185 0.0047
278 MIXED LIVER INJURY 14 0.0046
279 EXOPHTHALMOS 10 0.0046
280 TRISMUS 24 0.0046
281 POOR QUALITY DRUG ADMINISTERED 30 0.0046
282 LISTLESS 15 0.0045
283 BLOOD PRESSURE DIASTOLIC INCREASED 21 0.0045
284 OLIGURIA 28 0.0045
285 BUNDLE BRANCH BLOCK LEFT 19 0.0045
286 FEELING HOT 274 0.0045
287 CORONARY ARTERY THROMBOSIS 9 0.0045
288 INJECTION SITE NECROSIS 9 0.0044
289 OCULAR HYPERAEMIA 209 0.0044
290 SKIN REACTION 62 0.0044
291 HEPATIC CYTOLYSIS 56 0.0044
292 HEART RATE DECREASED 154 0.0044
293 EMBOLISM 36 0.0043
294 RASH GENERALISED 112 0.0043
295 OBSTRUCTIVE AIRWAYS DISORDER 48 0.0043
296 APHASIA 130 0.0043
297 HEPATIC ENCEPHALOPATHY 40 0.0043
298 PATENT DUCTUS ARTERIOSUS 17 0.0043
299 RASH PRURITIC 232 0.0043
300 MULTI-ORGAN FAILURE 74 0.0043
301 PERIPHERAL COLDNESS 58 0.0042
302 BRAIN DEATH 13 0.0042
303 DYSPNOEA 2379 0.0042
304 BLOOD PRESSURE DIASTOLIC DECREASED 31 0.0042
305 HYPOTENSION 836 0.0042
306 LANGUAGE DISORDER 9 0.0042
307 COMA SCALE ABNORMAL 12 0.0041
308 RASH VESICULAR 20 0.0041
309 MATERNAL EXPOSURE BEFORE PREGNANCY 28 0.0041
310 ELECTROCARDIOGRAM T WAVE INVERSION 9 0.0041
311 HYPOXIA 142 0.0040
312 TACHYCARDIA 357 0.0040
313 WHEEZING 237 0.0040
314 HYPERPARATHYROIDISM SECONDARY 10 0.0040
315 COMPUTERISED TOMOGRAM ABNORMAL 9 0.0040
316 JAUNDICE CHOLESTATIC 14 0.0040
317 HEART RATE ABNORMAL 22 0.0039
318 DRY THROAT 40 0.0039
319 ENDOTRACHEAL INTUBATION 11 0.0039
320 PANCREATITIS NECROTISING 9 0.0039
321 GLOMERULAR FILTRATION RATE DECREASED 48 0.0039
322 RASH PAPULAR 87 0.0039
323 TUMOUR LYSIS SYNDROME 34 0.0039
324 POST PROCEDURAL COMPLICATION 73 0.0038
325 UPPER RESPIRATORY TRACT CONGESTION 11 0.0038
326 ACIDOSIS 29 0.0038
327 FEELING COLD 105 0.0038
328 VENTRICULAR TACHYCARDIA 62 0.0038
329 MENINGITIS 25 0.0037
330 HYPERHIDROSIS 480 0.0037
331 FIBRIN D DIMER INCREASED 13 0.0037
332 HYPERCAPNIA 11 0.0036
333 HYPERSENSITIVITY 667 0.0036
334 LIQUID PRODUCT PHYSICAL ISSUE 26 0.0036
335 RESPIRATORY ACIDOSIS 14 0.0036
336 HYPOVOLAEMIC SHOCK 17 0.0035
337 CHRONIC GASTRITIS 8 0.0035
338 BLOOD PRESSURE SYSTOLIC INCREASED 69 0.0035
339 PRESYNCOPE 86 0.0035
340 EYELIDS PRURITUS 11 0.0035
341 MULTIPLE ORGAN DYSFUNCTION SYNDROME 100 0.0035
342 BLISTER 196 0.0035
343 WRONG DRUG ADMINISTERED 31 0.0035
344 INJECTION SITE VESICLES 21 0.0035
345 CARDIAC FAILURE ACUTE 23 0.0034
346 INTESTINAL ISCHAEMIA 19 0.0034
347 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 59 0.0034
348 GASTROINTESTINAL NECROSIS 10 0.0034
349 VENTRICULAR HYPOKINESIA 11 0.0034
350 RETCHING 73 0.0034
351 WRONG PRODUCT ADMINISTERED 23 0.0034
352 LACTIC ACIDOSIS 110 0.0034
353 DYSPHAGIA 322 0.0034
354 FEAR 91 0.0034
355 HAEMORRHAGE SUBCUTANEOUS 12 0.0034
356 PRODUCT CONTAMINATION 12 0.0034
357 RENAL INJURY 100 0.0034
358 PERIORBITAL SWELLING 19 0.0034
359 DISSEMINATED INTRAVASCULAR COAGULATION 47 0.0033
360 CHEILITIS 18 0.0033
361 ANHEDONIA 87 0.0033
362 HEART RATE INCREASED 325 0.0033
363 CEREBRAL HAEMATOMA 11 0.0033
364 FIBROSIS 10 0.0032
365 HYPOVOLAEMIA 19 0.0032
366 NECROSIS 18 0.0032
367 RENAL TUBULAR DISORDER 9 0.0032
368 PROTEIN TOTAL DECREASED 12 0.0032
369 HYPERKALAEMIA 111 0.0032
370 TUMOUR HAEMORRHAGE 9 0.0032
371 HAEMODYNAMIC INSTABILITY 24 0.0031
372 COUGH 881 0.0031
373 PHARYNGEAL DISORDER 9 0.0031
374 PHLEBITIS 16 0.0031
375 FAECAL INCONTINENCE 15 0.0031
376 INCONTINENCE 33 0.0031
377 RESTLESSNESS 114 0.0031
378 BRADYCARDIA 165 0.0031
379 SKIN SWELLING 27 0.0031
380 CEREBRAL INFARCTION 76 0.0031
381 ACUTE RESPIRATORY DISTRESS SYNDROME 55 0.0031
382 BLOOD CHLORIDE DECREASED 8 0.0031
383 SALIVARY HYPERSECRETION 31 0.0031
384 SINUS TACHYCARDIA 44 0.0031
385 HYPOVENTILATION 10 0.0031
386 CHOLANGITIS 19 0.0031
387 RASH 1335 0.0031
388 BLOOD CREATININE INCREASED 198 0.0030
389 NASAL DISCOMFORT 24 0.0030
390 TROPONIN INCREASED 23 0.0030
391 EMBOLISM VENOUS 9 0.0030
392 MYDRIASIS 38 0.0030
393 TUBULOINTERSTITIAL NEPHRITIS 55 0.0029
394 GOITRE 12 0.0029
395 DRUG ADMINISTRATION ERROR 89 0.0029
396 HEMIPARESIS 49 0.0029
397 ODYNOPHAGIA 17 0.0028
398 BLOOD LACTIC ACID INCREASED 15 0.0028
399 NEUTROPHIL COUNT INCREASED 29 0.0028
400 PRODUCT PHYSICAL ISSUE 57 0.0028
401 RENAL FAILURE 374 0.0028
402 HYPOTONIA 28 0.0028
403 ISCHAEMIC STROKE 50 0.0028
404 STUPOR 9 0.0028
405 AZOTAEMIA 11 0.0028
406 STEVENS-JOHNSON SYNDROME 61 0.0027
407 VOMITING 1287 0.0027
408 VENTRICULAR ARRHYTHMIA 10 0.0027
409 CEREBRAL ISCHAEMIA 14 0.0027
410 PNEUMOTHORAX 43 0.0027
411 ENCEPHALOPATHY 66 0.0027
412 ARTHRITIS BACTERIAL 11 0.0027
413 HYPOTHERMIA 27 0.0027
414 ACUTE CORONARY SYNDROME 22 0.0027
415 SUBARACHNOID HAEMORRHAGE 27 0.0026
416 OCCUPATIONAL EXPOSURE TO PRODUCT 17 0.0026
417 ACCIDENTAL EXPOSURE 11 0.0026
418 HYPOTHYROIDISM 84 0.0026
419 ABDOMINAL TENDERNESS 13 0.0026
420 CONJUNCTIVAL HAEMORRHAGE 10 0.0026
421 PRODUCT RESIDUE PRESENT 14 0.0026
422 HYPERVENTILATION 15 0.0026
423 PULMONARY OEDEMA 115 0.0026
424 TOXIC ENCEPHALOPATHY 13 0.0026
425 MUSCLE CONTRACTIONS INVOLUNTARY 9 0.0026
426 FOREIGN BODY IN THROAT 8 0.0025
427 NEUROTOXICITY 44 0.0025
428 HYPERBILIRUBINAEMIA 26 0.0025
429 SYNCOPE 250 0.0025
430 DELIRIUM 86 0.0025
431 RENAL FAILURE CHRONIC 19 0.0025
432 BACTERAEMIA 29 0.0024
433 FORMICATION 17 0.0024
434 HICCUPS 20 0.0024
435 METABOLIC ACIDOSIS 77 0.0024
436 ISCHAEMIA 11 0.0024
437 RESPIRATORY FAILURE 174 0.0024
438 ARTHRITIS INFECTIVE 11 0.0024
439 FLANK PAIN 22 0.0023
440 RESPIRATORY DISORDER 70 0.0023
441 SEIZURE 270 0.0023
442 RESPIRATION ABNORMAL 16 0.0023
443 DROOLING 16 0.0023
444 MEDICATION RESIDUE PRESENT 11 0.0023
445 MONOPLEGIA 10 0.0023
446 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
447 URINE OUTPUT DECREASED 20 0.0023
448 PHYSICAL DISABILITY 10 0.0023
449 BLOOD CREATINE INCREASED 10 0.0023
450 MOTOR DYSFUNCTION 23 0.0023
451 ASCITES 66 0.0022
452 GENERALISED TONIC-CLONIC SEIZURE 37 0.0022
453 OEDEMA 121 0.0022
454 APHONIA 31 0.0022
455 BURNING SENSATION 155 0.0022
456 LEUKOCYTOSIS 40 0.0022
457 BLOOD THYROID STIMULATING HORMONE DECREASED 10 0.0022
458 TREMOR 361 0.0022
459 MUSCLE RIGIDITY 26 0.0022
460 ATELECTASIS 21 0.0022
461 SINUS BRADYCARDIA 21 0.0022
462 ACUTE MYOCARDIAL INFARCTION 64 0.0022
463 HEMIPLEGIA 18 0.0022
464 MUSCLE TIGHTNESS 35 0.0022
465 HAEMOPTYSIS 60 0.0021
466 PRODUCT COLOUR ISSUE 11 0.0021
467 BLOOD ALBUMIN DECREASED 17 0.0021
468 SWELLING 199 0.0021
469 HEPATIC NECROSIS 8 0.0021
470 DISCOMFORT 129 0.0021
471 SENSORY LOSS 17 0.0021
472 RHINITIS 17 0.0021
473 CHOKING 41 0.0021
474 COMMUNICATION DISORDER 8 0.0021
475 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
476 BLOOD UREA INCREASED 35 0.0021
477 PALPITATIONS 244 0.0021
478 PANIC REACTION 15 0.0021
479 STRESS CARDIOMYOPATHY 12 0.0021
480 RASH MACULAR 72 0.0021
481 BLOOD PRESSURE INCREASED 314 0.0021
482 HEPATOCELLULAR INJURY 29 0.0020
483 DIALYSIS 29 0.0020
484 ECCHYMOSIS 14 0.0020
485 MUSCLE TWITCHING 47 0.0020
486 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 12 0.0020
487 HYPERVOLAEMIA 10 0.0020
488 INCOHERENT 13 0.0020
489 CHEST PAIN 370 0.0020
490 BRADYPHRENIA 13 0.0020
491 CORONARY ARTERY STENOSIS 10 0.0020
492 HEAD DISCOMFORT 35 0.0020
493 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 10 0.0020
494 SMALL INTESTINAL OBSTRUCTION 24 0.0019
495 EAR DISCOMFORT 20 0.0019
496 PYREXIA 674 0.0019
497 HAEMOLYSIS 15 0.0019
498 ASPARTATE AMINOTRANSFERASE INCREASED 103 0.0019
499 METASTASES TO LIVER 34 0.0019
500 SEPSIS 213 0.0019
501 SEPTIC SHOCK 83 0.0019
502 ENTEROCOLITIS 11 0.0019
503 SERUM FERRITIN INCREASED 10 0.0019
504 COMA 90 0.0019
505 LOW BIRTH WEIGHT BABY 15 0.0019
506 HYPERTENSIVE CRISIS 21 0.0019
507 PRODUCT ADMINISTRATION ERROR 38 0.0019
508 ORAL DISCOMFORT 26 0.0019
509 HYDRONEPHROSIS 14 0.0019
510 INJURY 131 0.0019
511 BODY TEMPERATURE INCREASED 38 0.0019
512 ABNORMAL SENSATION IN EYE 8 0.0019
513 RENAL IMPAIRMENT 156 0.0019
514 NAUSEA 1469 0.0019
515 RIGHT VENTRICULAR FAILURE 13 0.0019
516 HYPOAESTHESIA 277 0.0018
517 CONTRAINDICATED PRODUCT ADMINISTERED 56 0.0018
518 CYTOKINE RELEASE SYNDROME 37 0.0018
519 MICTURITION URGENCY 21 0.0018
520 CONVULSION 105 0.0018
521 ATRIOVENTRICULAR BLOCK 14 0.0018
522 END STAGE RENAL DISEASE 33 0.0018
523 HAEMORRHAGE INTRACRANIAL 27 0.0018
524 HEPATIC FAILURE 54 0.0018
525 FACIAL PARALYSIS 15 0.0018
526 NEUTROPHILIA 10 0.0018
527 DYSARTHRIA 66 0.0018
528 INCREASED UPPER AIRWAY SECRETION 9 0.0018
529 NEUROLOGICAL SYMPTOM 10 0.0017
530 PARALYSIS 25 0.0017
531 NO ADVERSE EVENT 314 0.0017
532 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 13 0.0017
533 RESPIRATORY DEPRESSION 21 0.0017
534 SPINAL OSTEOARTHRITIS 15 0.0017
535 METASTASES TO CENTRAL NERVOUS SYSTEM 22 0.0017
536 HAEMATEMESIS 43 0.0017
537 HYPOALBUMINAEMIA 13 0.0017
538 PULMONARY CONGESTION 22 0.0017
539 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
540 BLOOD PRESSURE ABNORMAL 33 0.0017
541 SKIN PLAQUE 14 0.0017
542 PNEUMONIA ASPIRATION 41 0.0016
543 PLEURAL EFFUSION 99 0.0016
544 COAGULOPATHY 27 0.0016
545 MENTAL STATUS CHANGES 45 0.0016
546 LOCAL SWELLING 28 0.0016
547 CLOSTRIDIUM DIFFICILE COLITIS 17 0.0016
548 LYMPHOEDEMA 11 0.0016
549 DISORIENTATION 63 0.0016
550 TRANSAMINASES INCREASED 35 0.0016
551 HYPERTONIA 9 0.0016
552 AMMONIA INCREASED 8 0.0016
553 SKIN DISCOLOURATION 72 0.0016
554 LIPASE INCREASED 12 0.0016
555 JOINT RANGE OF MOTION DECREASED 21 0.0016
556 HAEMOLYTIC ANAEMIA 14 0.0016
557 ENDOCARDITIS 8 0.0016
558 PANCREATITIS ACUTE 35 0.0016
559 ELECTROLYTE IMBALANCE 18 0.0015
560 FAILURE TO THRIVE 8 0.0015
561 CARDIOVASCULAR DISORDER 39 0.0015
562 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
563 CHRONIC KIDNEY DISEASE 116 0.0015
564 UNEVALUABLE EVENT 115 0.0015
565 OCULAR DISCOMFORT 17 0.0015
566 CHOLECYSTITIS 18 0.0015
567 SKIN ULCER 39 0.0015
568 ADVERSE REACTION 20 0.0015
569 SPEECH DISORDER 79 0.0015
570 HEPATIC STEATOSIS 28 0.0015
571 ALANINE AMINOTRANSFERASE INCREASED 92 0.0015
572 DIZZINESS 742 0.0015
573 GENERAL PHYSICAL CONDITION ABNORMAL 10 0.0015
574 PERICARDIAL EFFUSION 34 0.0015
575 SCAR 25 0.0015
576 VENTRICULAR EXTRASYSTOLES 15 0.0014
577 HYPOKALAEMIA 66 0.0014
578 ANGIOPATHY 8 0.0014
579 INCORRECT ROUTE OF DRUG ADMINISTRATION 51 0.0014
580 SCRATCH 15 0.0014
581 BLOOD BILIRUBIN INCREASED 38 0.0014
582 SKIN HYPERPIGMENTATION 12 0.0014
583 BRAIN INJURY 14 0.0014
584 PRODUCT USE IN UNAPPROVED INDICATION 346 0.0014
585 HEPATIC FUNCTION ABNORMAL 52 0.0014
586 DIPLOPIA 36 0.0014
587 EPILEPSY 42 0.0014
588 MUSCULAR WEAKNESS 156 0.0014
589 THROMBOCYTOPENIA 153 0.0014
590 GROIN PAIN 12 0.0014
591 PNEUMONITIS 37 0.0014
592 LUNG INFILTRATION 12 0.0014
593 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
594 SECRETION DISCHARGE 17 0.0014
595 LUNG INFECTION 21 0.0014
596 SHOCK HAEMORRHAGIC 11 0.0013
597 FACIAL PAIN 12 0.0013
598 TENDERNESS 14 0.0013
599 PARKINSONISM 13 0.0013
600 HEPATITIS B 8 0.0013
601 PULMONARY EMBOLISM 125 0.0013
602 INFARCTION 9 0.0013
603 NEPHROTIC SYNDROME 9 0.0013
604 WHITE BLOOD CELL COUNT INCREASED 50 0.0013
605 UROSEPSIS 12 0.0013
606 METASTASES TO LUNG 15 0.0013
607 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
608 LARGE INTESTINE PERFORATION 9 0.0013
609 SKIN LACERATION 14 0.0013
610 DEFAECATION URGENCY 9 0.0013
611 ATRIAL FIBRILLATION 125 0.0013
612 AGITATION 94 0.0013
613 PULMONARY HAEMORRHAGE 10 0.0013
614 TORSADE DE POINTES 10 0.0013
615 ABORTION INDUCED 12 0.0013
616 PYELONEPHRITIS 11 0.0013
617 RHINORRHOEA 82 0.0013
618 RENAL CYST 10 0.0013
619 ABDOMINAL PAIN 292 0.0013
620 ATRIAL FLUTTER 10 0.0013
621 DERMATITIS 26 0.0012
622 PANCYTOPENIA 69 0.0012
623 PARAESTHESIA 194 0.0012
624 PANCREATITIS 65 0.0012
625 POLYURIA 10 0.0012
626 VITREOUS FLOATERS 12 0.0012
627 HYPOPHOSPHATAEMIA 9 0.0012
628 LIVER FUNCTION TEST INCREASED 26 0.0012
629 PULMONARY MASS 18 0.0012
630 HYPONATRAEMIA 68 0.0012
631 MEDICATION ERROR 67 0.0012
632 ECZEMA 63 0.0012
633 BLOOD LACTATE DEHYDROGENASE INCREASED 19 0.0012
634 HAEMATURIA 41 0.0012
635 HYPERTENSION 253 0.0012
636 GRAND MAL CONVULSION 11 0.0012
637 CONFUSIONAL STATE 192 0.0012
638 LYMPHADENOPATHY 42 0.0012
639 CONJUNCTIVITIS 22 0.0012
640 HEPATOCELLULAR CARCINOMA 9 0.0012
641 AORTIC ANEURYSM 9 0.0012
642 MYOCLONUS 14 0.0012
643 GINGIVAL BLEEDING 16 0.0012
644 FLUID OVERLOAD 17 0.0012
645 PRODUCT CONTAINER ISSUE 10 0.0012
646 MUSCULOSKELETAL STIFFNESS 102 0.0012
647 HYPOCALCAEMIA 22 0.0012
648 ADRENAL INSUFFICIENCY 14 0.0012
649 STATUS EPILEPTICUS 13 0.0011
650 CHOLESTASIS 22 0.0011
651 URINARY RETENTION 38 0.0011
652 SKIN EXFOLIATION 96 0.0011
653 GAIT INABILITY 38 0.0011
654 DUODENAL ULCER 8 0.0011
655 TINNITUS 52 0.0011
656 EYE IRRITATION 65 0.0011
657 SENSORY DISTURBANCE 18 0.0011
658 MIOSIS 9 0.0011
659 HAEMATOMA 29 0.0011
660 HAEMATOCRIT DECREASED 22 0.0011
661 PROTEINURIA 21 0.0011
662 ACUTE HEPATIC FAILURE 15 0.0011
663 PREMATURE BABY 33 0.0011
664 HYPERAESTHESIA 9 0.0011
665 EMOTIONAL DISTRESS 132 0.0011
666 PNEUMONIA BACTERIAL 10 0.0011
667 MATERNAL EXPOSURE DURING PREGNANCY 97 0.0011
668 CARDIAC FAILURE 87 0.0011
669 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24 0.0011
670 BONE MARROW FAILURE 22 0.0011
671 HIATUS HERNIA 14 0.0011
672 SKIN DISORDER 36 0.0011
673 ARRHYTHMIA 51 0.0011
674 C-REACTIVE PROTEIN INCREASED 39 0.0011
675 INTESTINAL PERFORATION 12 0.0011
676 ABDOMINAL PAIN LOWER 27 0.0011
677 THIRST 19 0.0011
678 VISION BLURRED 146 0.0011
679 DYSSTASIA 31 0.0011
680 LIVER INJURY 26 0.0011
681 PULMONARY HYPERTENSION 22 0.0011
682 ECONOMIC PROBLEM 16 0.0011
683 SPUTUM DISCOLOURED 10 0.0011
684 BLOOD MAGNESIUM DECREASED 9 0.0010
685 VERTIGO 63 0.0010
686 PRODUCTIVE COUGH 49 0.0010
687 NERVOUS SYSTEM DISORDER 32 0.0010
688 HAEMORRHAGIC STROKE 8 0.0010
689 NEUROLEPTIC MALIGNANT SYNDROME 12 0.0010
690 PHOTOPHOBIA 19 0.0010
691 ULCER 16 0.0010
692 DYSURIA 37 0.0010
693 COLITIS 38 0.0010
694 RECTAL HAEMORRHAGE 43 0.0010
695 STAPHYLOCOCCAL INFECTION 33 0.0010
696 BLOOD PRESSURE FLUCTUATION 24 0.0010
697 OROPHARYNGEAL PAIN 91 0.0010
698 INTERNATIONAL NORMALISED RATIO INCREASED 28 0.0010
699 DECUBITUS ULCER 8 0.0010
700 FEBRILE NEUTROPENIA 65 0.0010
701 BLOOD CALCIUM DECREASED 11 0.0010
702 DRUG INTERACTION 155 0.0010
703 OEDEMA PERIPHERAL 119 0.0010
704 EJECTION FRACTION DECREASED 15 0.0010
705 DEFORMITY 9 0.0010
706 MELAENA 21 0.0010
707 SKIN LESION 26 0.0009
708 VASCULITIS 11 0.0009
709 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 22 0.0009
710 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
711 ABSCESS 15 0.0009
712 MALAISE 410 0.0009
713 HYPERLIPIDAEMIA 11 0.0009
714 NECK PAIN 51 0.0009
715 PSYCHOMOTOR HYPERACTIVITY 15 0.0009
716 NERVE INJURY 10 0.0009
717 ASTHENIA 335 0.0009
718 ANXIETY 253 0.0009
719 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
720 EYELID PTOSIS 9 0.0009
721 OSTEOMYELITIS 16 0.0009
722 IMPAIRED GASTRIC EMPTYING 12 0.0009
723 MYOCARDIAL ISCHAEMIA 10 0.0009
724 JOINT STIFFNESS 23 0.0009
725 MENTAL DISORDER 38 0.0009
726 EYE DISCHARGE 9 0.0009
727 RHABDOMYOLYSIS 36 0.0009
728 HYPOMAGNESAEMIA 12 0.0009
729 SPINAL PAIN 10 0.0009
730 BLOOD SODIUM DECREASED 16 0.0008
731 LYMPHOCYTE COUNT DECREASED 15 0.0008
732 HEART RATE IRREGULAR 19 0.0008
733 CEREBRAL HAEMORRHAGE 30 0.0008
734 BACK PAIN 194 0.0008
735 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
736 GENERAL PHYSICAL HEALTH DETERIORATION 96 0.0008
737 DIZZINESS POSTURAL 8 0.0008
738 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
739 SINUS CONGESTION 11 0.0008
740 DENTAL CARIES 9 0.0008
741 CELLULITIS 41 0.0008
742 CARDIOMEGALY 10 0.0008
743 CARDIOMYOPATHY 12 0.0008
744 BLOOD POTASSIUM INCREASED 13 0.0008
745 LETHARGY 46 0.0008
746 DRUG-INDUCED LIVER INJURY 25 0.0008
747 PANIC ATTACK 29 0.0008
748 EMPHYSEMA 8 0.0008
749 ABDOMINAL DISTENSION 82 0.0008
750 PERIPHERAL SWELLING 121 0.0008
751 RIB FRACTURE 16 0.0008
752 MUSCULOSKELETAL CHEST PAIN 12 0.0008
753 INFLAMMATION 40 0.0008
754 CAESAREAN SECTION 9 0.0008
755 HEADACHE 484 0.0008
756 EAR PAIN 15 0.0008
757 INFUSION RELATED REACTION 51 0.0008
758 SPLENOMEGALY 9 0.0008
759 IMPAIRED QUALITY OF LIFE 11 0.0008
760 DYSKINESIA 31 0.0008
761 FEELING ABNORMAL 182 0.0008
762 MOUTH ULCERATION 16 0.0008
763 MUSCULOSKELETAL DISCOMFORT 13 0.0008
764 DYSGEUSIA 56 0.0008
765 PLATELET COUNT DECREASED 80 0.0007
766 BREAST CANCER METASTATIC 8 0.0007
767 INJECTION SITE SWELLING 57 0.0007
768 HEPATITIS 19 0.0007
769 ANAEMIA 140 0.0007
770 ANGINA PECTORIS 21 0.0007
771 BLOOD POTASSIUM DECREASED 22 0.0007
772 CORONARY ARTERY OCCLUSION 10 0.0007
773 GASTROINTESTINAL PAIN 8 0.0007
774 PHARYNGITIS 9 0.0007
775 OSTEOPENIA 11 0.0007
776 ILEUS 9 0.0007
777 SOMNOLENCE 145 0.0007
778 PELVIC PAIN 13 0.0007
779 MYALGIA 121 0.0007
780 PAIN 434 0.0007
781 EYE DISORDER 23 0.0007
782 SUBDURAL HAEMATOMA 10 0.0007
783 DEHYDRATION 93 0.0007
784 CORONARY ARTERY DISEASE 21 0.0007
785 EYE PAIN 39 0.0007
786 DYSPNOEA EXERTIONAL 26 0.0007
787 IMMUNE SYSTEM DISORDER 9 0.0007
788 COVID-19 PNEUMONIA 8 0.0007
789 IMMUNODEFICIENCY 10 0.0007
790 QUALITY OF LIFE DECREASED 9 0.0007
791 GASTROOESOPHAGEAL REFLUX DISEASE 54 0.0007
792 JAUNDICE 18 0.0007
793 HYPOPHAGIA 17 0.0007
794 HYPERGLYCAEMIA 24 0.0007
795 NEURALGIA 16 0.0007
796 DISABILITY 13 0.0007
797 SKIN BURNING SENSATION 47 0.0007
798 LIVER FUNCTION TEST ABNORMAL 19 0.0007
799 DEAFNESS 17 0.0006
800 DEVICE RELATED INFECTION 10 0.0006
801 MUCOSAL INFLAMMATION 17 0.0006
802 DRY MOUTH 52 0.0006
803 HYPOGLYCAEMIA 31 0.0006
804 GASTRIC ULCER 12 0.0006
805 RED BLOOD CELL COUNT DECREASED 18 0.0006
806 UPPER RESPIRATORY TRACT INFECTION 29 0.0006
807 OFF LABEL USE 546 0.0006
808 INTERSTITIAL LUNG DISEASE 30 0.0006
809 DYSTONIA 12 0.0006
810 ELECTROCARDIOGRAM QT PROLONGED 22 0.0006
811 METASTASES TO BONE 10 0.0006
812 LIVER DISORDER 27 0.0006
813 MOBILITY DECREASED 43 0.0006
814 HOT FLUSH 45 0.0006
815 PERICARDITIS 10 0.0006
816 CANDIDA INFECTION 10 0.0006
817 NIGHT SWEATS 19 0.0006
818 BACTERIAL INFECTION 11 0.0006
819 BLINDNESS 24 0.0006
820 NEUTROPHIL COUNT DECREASED 24 0.0006
821 INJECTION SITE RASH 18 0.0006
822 GASTROINTESTINAL HAEMORRHAGE 49 0.0006
823 HEPATIC CIRRHOSIS 11 0.0006
824 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
825 BRAIN FOG 9 0.0006
826 VISUAL IMPAIRMENT 71 0.0006
827 FOETAL EXPOSURE DURING PREGNANCY 46 0.0006
828 PREMATURE DELIVERY 9 0.0006
829 EATING DISORDER 12 0.0006
830 PRODUCT QUALITY ISSUE 76 0.0006
831 HEPATIC ENZYME INCREASED 38 0.0006
832 MUSCLE SPASMS 101 0.0005
833 TASTE DISORDER 11 0.0005
834 EXPIRED PRODUCT ADMINISTERED 18 0.0005
835 DRY EYE 27 0.0005
836 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
837 AGRANULOCYTOSIS 10 0.0005
838 ORAL PAIN 12 0.0005
839 DISEASE PROGRESSION 63 0.0005
840 LUNG DISORDER 26 0.0005
841 NEUTROPENIA 72 0.0005
842 PAIN IN EXTREMITY 154 0.0005
843 ABDOMINAL DISCOMFORT 87 0.0005
844 NEOPLASM PROGRESSION 18 0.0005
845 PRESCRIBED OVERDOSE 10 0.0005
846 COGNITIVE DISORDER 24 0.0005
847 CEREBROVASCULAR ACCIDENT 87 0.0005
848 IRRITABLE BOWEL SYNDROME 11 0.0005
849 PRODUCT PRESCRIBING ERROR 12 0.0005
850 NERVOUSNESS 26 0.0005
851 DIARRHOEA 316 0.0005
852 CHROMATURIA 11 0.0005
853 OSTEONECROSIS 16 0.0005
854 HAEMOGLOBIN DECREASED 50 0.0005
855 PNEUMONIA 157 0.0005
856 DRUG LEVEL INCREASED 8 0.0005
857 DEVICE DISLOCATION 21 0.0005
858 PERITONITIS 10 0.0005
859 PAIN OF SKIN 13 0.0005
860 MYOCARDIAL INFARCTION 84 0.0005
861 INTESTINAL OBSTRUCTION 18 0.0005
862 DEEP VEIN THROMBOSIS 31 0.0005
863 AMNESIA 31 0.0005
864 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
865 HALLUCINATION, VISUAL 10 0.0005
866 DECREASED APPETITE 110 0.0005
867 MUSCULOSKELETAL DISORDER 9 0.0005
868 PULMONARY FIBROSIS 9 0.0005
869 DIVERTICULITIS 13 0.0005
870 ADVERSE EVENT 43 0.0005
871 ABDOMINAL PAIN UPPER 96 0.0005
872 PAIN IN JAW 13 0.0005
873 MUSCULOSKELETAL PAIN 24 0.0005
874 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
875 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
876 CARDIAC FAILURE CONGESTIVE 36 0.0004
877 MALIGNANT NEOPLASM PROGRESSION 45 0.0004
878 PRODUCT USE ISSUE 82 0.0004
879 EXPOSURE DURING PREGNANCY 27 0.0004
880 HAEMORRHAGE 45 0.0004
881 VISUAL ACUITY REDUCED 14 0.0004
882 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
883 DEPRESSED MOOD 22 0.0004
884 CONTUSION 40 0.0004
885 FAECES DISCOLOURED 9 0.0004
886 ARTHRALGIA 171 0.0004
887 THROMBOSIS 33 0.0004
888 OVERDOSE 88 0.0004
889 POLLAKIURIA 17 0.0004
890 MOVEMENT DISORDER 13 0.0004
891 GASTROINTESTINAL DISORDER 36 0.0004
892 EPISTAXIS 30 0.0004
893 BLOOD GLUCOSE INCREASED 75 0.0004
894 GAIT DISTURBANCE 76 0.0004
895 GASTRIC CANCER 10 0.0004
896 INFECTION 57 0.0004
897 FATIGUE 303 0.0004
898 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
899 BALANCE DISORDER 33 0.0004
900 GASTRITIS 10 0.0004
901 LEUKOPENIA 19 0.0004
902 INJECTION SITE PAIN 116 0.0004
903 OSTEOARTHRITIS 16 0.0004
904 CARDIAC DISORDER 35 0.0004
905 CONDITION AGGRAVATED 113 0.0004
906 ASTHMA 42 0.0004
907 CONSTIPATION 81 0.0004
908 MENTAL IMPAIRMENT 9 0.0004
909 DISTURBANCE IN ATTENTION 20 0.0004
910 FREQUENT BOWEL MOVEMENTS 10 0.0004
911 OSTEOPOROSIS 15 0.0004
912 ABASIA 9 0.0004
913 PROCEDURAL PAIN 10 0.0004
914 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
915 BONE PAIN 21 0.0004
916 WOUND 10 0.0004
917 GLOSSODYNIA 8 0.0004
918 BLOOD GLUCOSE DECREASED 17 0.0004
919 HAEMATOCHEZIA 19 0.0003
920 RENAL DISORDER 16 0.0003
921 DEPRESSION 78 0.0003
922 FALL 112 0.0003
923 CHOLELITHIASIS 11 0.0003
924 THERAPY NON-RESPONDER 15 0.0003
925 ACCIDENTAL OVERDOSE 12 0.0003
926 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
927 SLEEP DISORDER 23 0.0003
928 DEATH 280 0.0003
929 ABORTION SPONTANEOUS 13 0.0003
930 LIMB DISCOMFORT 10 0.0003
931 URINARY TRACT INFECTION 54 0.0003
932 HYPERSOMNIA 9 0.0003
933 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
934 ACCIDENTAL EXPOSURE TO PRODUCT 32 0.0003
935 MYELOSUPPRESSION 11 0.0003
936 NEPHROLITHIASIS 14 0.0003
937 ABNORMAL BEHAVIOUR 12 0.0003
938 VIRAL INFECTION 10 0.0003
939 AGGRESSION 15 0.0003
940 BRONCHITIS 22 0.0003
941 TOXICITY TO VARIOUS AGENTS 50 0.0003
942 NEUROPATHY PERIPHERAL 28 0.0003
943 ARTHRITIS 23 0.0003
944 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
945 BONE DENSITY DECREASED 9 0.0003
946 IRRITABILITY 17 0.0003
947 HALLUCINATION 21 0.0003
948 IMPAIRED HEALING 9 0.0003
949 INJECTION SITE ERYTHEMA 33 0.0003
950 DERMATITIS ATOPIC 14 0.0003
951 STOMATITIS 16 0.0003
952 JOINT SWELLING 31 0.0003
953 PLASMA CELL MYELOMA 10 0.0003
954 NEOPLASM MALIGNANT 17 0.0003
955 ILLNESS 26 0.0003
956 CYSTITIS 8 0.0003
957 WEIGHT DECREASED 68 0.0002
958 DRY SKIN 32 0.0002
959 ACNE 18 0.0002
960 ARTHROPATHY 13 0.0002
961 DYSPEPSIA 23 0.0002
962 HYPOACUSIS 10 0.0002
963 INTENTIONAL PRODUCT USE ISSUE 20 0.0002
964 EXTRA DOSE ADMINISTERED 9 0.0002
965 DEVICE MALFUNCTION 15 0.0002
966 FLATULENCE 12 0.0002
967 HERPES ZOSTER 12 0.0002
968 MEMORY IMPAIRMENT 28 0.0002
969 CATARACT 12 0.0002
970 DEVICE BREAKAGE 8 0.0002
971 BLOOD CHOLESTEROL INCREASED 9 0.0002
972 ADVERSE DRUG REACTION 17 0.0002
973 INSOMNIA 49 0.0002
974 DRUG INTOLERANCE 17 0.0002
975 INFLUENZA LIKE ILLNESS 14 0.0002
976 DRUG INEFFECTIVE 210 0.0002
977 ALOPECIA 31 0.0002
978 DIABETES MELLITUS 12 0.0002
979 MIGRAINE 15 0.0002
980 SINUSITIS 16 0.0002
981 COVID-19 26 0.0001
982 ILL-DEFINED DISORDER 9 0.0001
983 INFLUENZA 16 0.0001
984 INJECTION SITE PRURITUS 9 0.0001
985 NASOPHARYNGITIS 23 0.0001
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
987 INJECTION SITE HAEMORRHAGE 9 0.0001
988 HOSPITALISATION 17 0.0001
989 WEIGHT INCREASED 23 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
991 DEVICE ISSUE 8 0.0001
992 DRUG DEPENDENCE 13 0.0001
993 PSORIASIS 10 0.0001
994 PRODUCT DOSE OMISSION ISSUE 22 0.0001
995 INCORRECT DOSE ADMINISTERED 17 0.0001